indazoles has been researched along with Chondrosarcoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, DM; Chow, W; Frankel, P; Hartner, L; Milhem, M; Okuno, S; Ruel, C; Staddon, A; Undevia, S | 1 |
| Davidson, D; Jones, RL; Katz, D; Loggers, ET; Pollack, SM; Rodler, ET | 1 |
| Araki, N | 1 |
| Bernabeu, D; Blay, JY; Brenca, M; Brich, S; Casali, PG; Castelli, C; Collini, P; Cruz, J; Dagrada, GP; de Alava, E; Dumont, S; Ferrari, S; Frezza, AM; Grignani, G; Gutierrez, A; Hindi, N; Italiano, A; Karanian, M; LeCesne, A; Lopez-Pousa, A; Maestro, R; Martin-Broto, J; Morosi, C; Palmerini, E; Penel, N; Racanelli, D; Redondo, A; Stacchiotti, S; Vallacchi, V; Vaz Salgado, MA | 1 |
| Azraq, Y; Eleyan, F; Gill, S; Katz, D; Merimsky, O; Peretz, T | 1 |
2 trial(s) available for indazoles and Chondrosarcoma
| Article | Year |
|---|---|
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chondrosarcoma; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Metastasis; Progression-Free Survival; Prospective Studies; Pyrimidines; Sulfonamides | 2020 |
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chondrosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Staging; Neoplasms, Connective and Soft Tissue; Pyrimidines; Retrospective Studies; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2019 |
3 other study(ies) available for indazoles and Chondrosarcoma
| Article | Year |
|---|---|
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chondrosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms, Connective and Soft Tissue; Pyrimidines; Ramucirumab; Retrospective Studies; Sulfonamides; Treatment Outcome | 2017 |
Fusion gene-oriented precision medicine in soft tissue sarcoma.
Topics: Chondrosarcoma; Humans; Indazoles; Precision Medicine; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2019 |
Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chondrosarcoma; Disease Progression; Drug Administration Schedule; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Metastasis; Pyrimidines; Retrospective Studies; Sarcoma; Sirolimus; Sulfonamides; Survival Analysis; Treatment Outcome; Young Adult | 2016 |